|Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1|
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
|Cross-laboratory analysis of brain cell type transcriptomes with applications to interpretation of bulk tissue data|
BO Mancarci, L Toker, SJ Tripathy, B Li, B Rocco, E Sibille, P Pavlidis
eneuro 4 (6), 2017
|Transcriptomic evidence for alterations in astrocytes and parvalbumin interneurons in subjects with bipolar disorder and schizophrenia|
L Toker, BO Mancarci, S Tripathy, P Pavlidis
Biological psychiatry 84 (11), 787-796, 2018
|Trehalose induced antidepressant-like effects and autophagy enhancement in mice|
NZ Kara, L Toker, G Agam, GW Anderson, RH Belmaker, H Einat
Psychopharmacology 229, 367-375, 2013
|Transcriptomic correlates of neuron electrophysiological diversity|
SJ Tripathy, L Toker, B Li, CL Crichlow, D Tebaykin, BO Mancarci, ...
PLoS computational biology 13 (10), e1005814, 2017
|IP3 accumulation and/or inositol depletion: two downstream lithium’s effects that may mediate its behavioral and cellular changes|
Y Sade, L Toker, NZ Kara, H Einat, S Rapoport, D Moechars, GT Berry, ...
Translational psychiatry 6 (12), e968-e968, 2016
|Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain|
L Toker, GT Tran, J Sundaresan, OB Tysnes, G Alves, K Haugarvoll, ...
Molecular neurodegeneration 16 (1), 1-20, 2021
|Inositol-related gene knockouts mimic lithium’s effect on mitochondrial function|
L Toker, Y Bersudsky, I Plaschkes, V Chalifa-Caspi, GT Berry, ...
Neuropsychopharmacology 39 (2), 319-328, 2014
|Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: a potential treatment target?|
GA Horvath, M Demos, C Shyr, A Matthews, L Zhang, S Race, ...
Molecular genetics and metabolism 117 (1), 42-48, 2016
|Whose sample is it anyway? Widespread misannotation of samples in transcriptomics studies [version 2; peer review|
L Toker, M Feng, P Pavlidis
|Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition|
GS Nido, F Dick, L Toker, K Petersen, G Alves, OB Tysnes, I Jonassen, ...
Acta neuropathologica communications 8 (1), 1-14, 2020
|Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects|
L Toker, G Agam
Neuropsychiatric disease and treatment, 2441-2447, 2015
|Assessing transcriptome quality in patch-seq datasets|
SJ Tripathy, L Toker, C Bomkamp, BO Mancarci, M Belmadani, P Pavlidis
Frontiers in Molecular Neuroscience 11, 363, 2018
|A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population|
B Brakedal, L Toker, K Haugarvoll, C Tzoulis
npj Parkinson's Disease 8 (1), 19, 2022
|Lithium, inositol and mitochondria|
L Toker, G Agam
ACS Chemical Neuroscience 5 (6), 411-412, 2014
|Molecular effects of lithium are partially mimicked by inositol-monophosphatase (IMPA) 1 knockout mice in a brain region-dependent manner|
O Damri, Y Sade, L Toker, Y Bersudsky, RH Belmaker, G Agam, AN Azab
European Neuropsychopharmacology 25 (3), 425-434, 2015
|Beware of your mouse strain; differential effects of lithium on behavioral and neurochemical phenotypes in Harlan ICR mice bred in Israel or the USA|
Y Sade, NZ Kara, L Toker, Y Bersudsky, H Einat, G Agam
Pharmacology Biochemistry and Behavior 124, 36-39, 2014
|Gene-expression studies in understanding the mechanism of action of lithium|
L Toker, RH Belmaker, G Agam
Expert review of neurotherapeutics 12 (1), 93-97, 2012
|BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s disease|
Z Vitic, H Safory, VM Jovanovic, Y Sarusi, A Stavsky, J Kahn, A Kuzmina, ...
Brain 144 (2), e15-e15, 2021
|Chronic oral carbamazepine treatment elicits mood-stabilising effects in mice|
NZ Kara, O Karpel, L Toker, G Agam, RH Belmaker, H Einat
Acta Neuropsychiatrica 26 (1), 29-34, 2014